233 related articles for article (PubMed ID: 33841413)
1. Soluble MD-2 and Heme in Sickle Cell Disease Plasma Promote Pro-Inflammatory Signaling in Endothelial Cells.
Zhang P; Nguyen J; Abdulla F; Nelson AT; Beckman JD; Vercellotti GM; Belcher JD
Front Immunol; 2021; 12():632709. PubMed ID: 33841413
[TBL] [Abstract][Full Text] [Related]
2. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.
Belcher JD; Chen C; Nguyen J; Milbauer L; Abdulla F; Alayash AI; Smith A; Nath KA; Hebbel RP; Vercellotti GM
Blood; 2014 Jan; 123(3):377-90. PubMed ID: 24277079
[TBL] [Abstract][Full Text] [Related]
3. Endothelial TLR4 Expression Mediates Vaso-Occlusive Crisis in Sickle Cell Disease.
Beckman JD; Abdullah F; Chen C; Kirchner R; Rivera-Rodriguez D; Kiser ZM; Nguyen A; Zhang P; Nguyen J; Hebbel RP; Belcher JD; Vercellotti GM
Front Immunol; 2020; 11():613278. PubMed ID: 33542720
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Heme-Induced Inflammation Using MicroRNA-Loaded Liposomes: Implications for Hemolytic Disorders Such as Malaria and Sickle Cell Disease.
Bashi A; Lekpor C; Hood JL; Thompson WE; Stiles JK; Driss A
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069257
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Heme Activation Site on the MD-2/TLR4 Complex.
Belcher JD; Zhang P; Nguyen J; Kiser ZM; Nath KA; Hu J; Trent JO; Vercellotti GM
Front Immunol; 2020; 11():1370. PubMed ID: 32695117
[TBL] [Abstract][Full Text] [Related]
6. Critical role of C5a in sickle cell disease.
Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD
Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594
[TBL] [Abstract][Full Text] [Related]
7. The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease.
Gbotosho OT; Kapetanaki MG; Kato GJ
Front Immunol; 2020; 11():561917. PubMed ID: 33584641
[TBL] [Abstract][Full Text] [Related]
8. Macrophage metabolic rewiring improves heme-suppressed efferocytosis and tissue damage in sickle cell disease.
Sharma R; Antypiuk A; Vance SZ; Manwani D; Pearce Q; Cox JE; An X; Yazdanbakhsh K; Vinchi F
Blood; 2023 Jun; 141(25):3091-3108. PubMed ID: 36952641
[TBL] [Abstract][Full Text] [Related]
9. Endothelial Barrier Integrity Is Disrupted
Santaterra VAG; Fiusa MML; Hounkpe BW; Chenou F; Tonasse WV; da Costa LNG; Garcia-Weber D; Domingos IF; de Lima F; Borba-Junior IT; Araújo ADS; Lucena-Araújo AR; Bezerra MAC; Dos Santos MNN; Costa FF; Millán J; De Paula EV
Front Immunol; 2020; 11():535147. PubMed ID: 33381108
[TBL] [Abstract][Full Text] [Related]
10. Recombinant soluble forms of extracellular TLR4 domain and MD-2 inhibit lipopolysaccharide binding on cell surface and dampen lipopolysaccharide-induced pulmonary inflammation in mice.
Mitsuzawa H; Nishitani C; Hyakushima N; Shimizu T; Sano H; Matsushima N; Fukase K; Kuroki Y
J Immunol; 2006 Dec; 177(11):8133-9. PubMed ID: 17114488
[TBL] [Abstract][Full Text] [Related]
11. Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.
Belcher JD; Chen C; Nguyen J; Abdulla F; Zhang P; Nguyen H; Nguyen P; Killeen T; Miescher SM; Brinkman N; Nath KA; Steer CJ; Vercellotti GM
PLoS One; 2018; 13(4):e0196455. PubMed ID: 29694434
[TBL] [Abstract][Full Text] [Related]
12. Featured Article: Depletion of HDL
Soupene E; Larkin SK; Kuypers FA
Exp Biol Med (Maywood); 2017 Jun; 242(12):1244-1253. PubMed ID: 28436274
[TBL] [Abstract][Full Text] [Related]
13. HbS promotes TLR4-mediated monocyte activation and proinflammatory cytokine production in sickle cell disease.
Allali S; Rignault-Bricard R; de Montalembert M; Taylor M; Bouceba T; Hermine O; Maciel TT
Blood; 2022 Nov; 140(18):1972-1982. PubMed ID: 35984906
[TBL] [Abstract][Full Text] [Related]
14. Heme Induces IL-6 and Cardiac Hypertrophy Genes Transcripts in Sickle Cell Mice.
Gbotosho OT; Kapetanaki MG; Ghosh S; Villanueva FS; Ofori-Acquah SF; Kato GJ
Front Immunol; 2020; 11():1910. PubMed ID: 32973791
[TBL] [Abstract][Full Text] [Related]
15. Assessment of total and unbound cell-free heme in plasma of patients with sickle cell disease.
Vissa M; Larkin SK; Vichinsky EP; Kuypers FA; Soupene E
Exp Biol Med (Maywood); 2023 May; 248(10):897-907. PubMed ID: 36941786
[TBL] [Abstract][Full Text] [Related]
16. Heme Causes Pain in Sickle Mice
Lei J; Paul J; Wang Y; Gupta M; Vang D; Thompson S; Jha R; Nguyen J; Valverde Y; Lamarre Y; Jones MK; Gupta K
Antioxid Redox Signal; 2021 Feb; 34(4):279-293. PubMed ID: 32729340
[No Abstract] [Full Text] [Related]
17. Myeloid differentiation factor-2 activates monocytes in patients with dilated cardiomyopathy.
Feldtmann R; Kümmel A; Chamling B; Strohbach A; Lehnert K; Gross S; Loerzer L; Riad A; Lindner D; Westermann D; Fielitz J; Dörr M; Felix SB
Immunology; 2022 Sep; 167(1):40-53. PubMed ID: 35502635
[TBL] [Abstract][Full Text] [Related]
18. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice.
Belcher JD; Chen C; Nguyen J; Abdulla F; Nguyen P; Nguyen M; Okeley NM; Benjamin DR; Senter PD; Vercellotti GM
PLoS One; 2015; 10(2):e0117772. PubMed ID: 25706118
[TBL] [Abstract][Full Text] [Related]
19. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
[TBL] [Abstract][Full Text] [Related]
20. MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease.
Belcher JD; Nguyen J; Chen C; Abdulla F; Conglin R; Ivy ZK; Cummings J; Dudler T; Vercellotti GM
Transl Res; 2022 Nov; 249():1-12. PubMed ID: 35878790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
